| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0036 | 0.9 |